Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Jan 14, 2019
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Award
Stock Option (Right to Buy)
2019-01-10+132,000→ 132,000 totalExercise: $4.64Exp: 2029-01-09→ Common Stock (132,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the Option vests one year after January 10, 2019; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.